Maria José Sparça Salles
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maria José Sparça Salles has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Camila Salvador Sestario
Universidade Estadual de Londrina, Brasil
6 shared publications - Aline Campos Zeffa
Universidade Estadual de Londrina, Brasil
4 shared publications Caio Cezar Nantes Martins
Laboratory of Developmental Toxicology, Department of Biology State University of Londrina Londrina Paraná Brazil
3 shared publications- Caio Cezar Nantes Martins
Laboratory of Developmental Toxicology, Department of General Biology, State University of Londrina, Londrina, Brazil
3 shared publications - Estefânia Gastaldello Moreira
Health Sciences Graduate Program, Health Sciences Center, State University of Londrina, Londrina, Brazil
3 shared publications - Gabriel de Araújo Costa
Pharmacology Department, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
3 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in RGO - Revista Gaúcha de Odontologia
- Vol. 74
Escitalopram induces morphometric and collagen changes in salivary glands of pregnant mice
Objective: This study aimed to evaluate the effects of exposure to Escitalopram Oxalate on morphometric parameters of salivary glands of pregnant mice. Methods: Twenty pregnant Swiss mice (Mus musculus) were equally divided into treated and control groups, which received 20 mg/kg of Escitalopram and sterile saline, respectively, via gavage, daily, from the 5th to the 17th day of pregnancy. On the 18th day, after euthanasia, salivary glands were collected and passed through histological procedures. Under optical microscopy, acinar diameter (in µm) and area (in µm2), ductal thickness (in µm), and quantity of type I collagen (area, in µm2) from parotid, sublingual, and submandibular glands were measured. Statistical analysis was carried out with the Student’s t test for parametric data and the Mann-Whitney test for non parametric data, with 5% significance (GraphPad Prism 5). Results: Acinar areas (C: 1207.0 ± 315.2; T: 1662.0 ± 508.0; p=0.002) and diameters (C: 34.3 [33.3-37.8]; T: 41.0 [34.9-47.4]; p=0.008) from sublingual glands and acinar areas (C: 1009.0 ± 406.3; T: 1378.0 ± 464.2; p=0.005) and diameters (C: 37.9 ± 10.1; T: 45.3 ±6.8; p=0.05) from submandibular glands were statistically bigger in the treated group than the control group. The quantity of type I collagen was statistically lower in the treated group compared to the control group (C: 4399[3346.0-7092.0]; T: 3695.0 [2948.0-4792.0]; p=0.0003). Conclusion: Escitalopram promotes an adverse effect, causing morphological and structural alterations in the salivary glands of pregnant mice.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in RGO - Revista Gaúcha de Odontologia
- Vol. 74
Open AccessEscitalopram induces morphometric and collagen changes in salivary glands of pregnant mice
Objective: This study aimed to evaluate the effects of exposure to Escitalopram Oxalate on morphometric parameters of salivary glands of pregnant mice. Methods: Twenty pregnant Swiss mice (Mus musculus) were equally divided into treated and control groups, which received 20 mg/kg of Escitalopram and sterile saline, respectively, via gavage, daily, from the 5th to the 17th day of pregnancy. On the 18th day, after euthanasia, salivary glands were collected and passed through histological procedures. Under optical microscopy, acinar diameter (in µm) and area (in µm2), ductal thickness (in µm), and quantity of type I collagen (area, in µm2) from parotid, sublingual, and submandibular glands were measured. Statistical analysis was carried out with the Student’s t test for parametric data and the Mann-Whitney test for non parametric data, with 5% significance (GraphPad Prism 5). Results: Acinar areas (C: 1207.0 ± 315.2; T: 1662.0 ± 508.0; p=0.002) and diameters (C: 34.3 [33.3-37.8]; T: 41.0 [34.9-47.4]; p=0.008) from sublingual glands and acinar areas (C: 1009.0 ± 406.3; T: 1378.0 ± 464.2; p=0.005) and diameters (C: 37.9 ± 10.1; T: 45.3 ±6.8; p=0.05) from submandibular glands were statistically bigger in the treated group than the control group. The quantity of type I collagen was statistically lower in the treated group compared to the control group (C: 4399[3346.0-7092.0]; T: 3695.0 [2948.0-4792.0]; p=0.0003). Conclusion: Escitalopram promotes an adverse effect, causing morphological and structural alterations in the salivary glands of pregnant mice.
- 3 April 2025
- Published by Wiley in Birth Defects Research
- Vol. 117 (4) , e2468
Postnatal Effects of Prenatal Exposure to Periodontitis in Wistar Rat Pups
Background: Periodontitis during pregnancy is associated with preterm births and low birth weight. This study evaluated how experimental periodontitis induced in female rats impacts the physical development, motor skills, and dental and maxillary development of their pups.Method: Pregnant Wistar rats were divided into the control group (C, n = 12) and the induced periodontal disease group (P, n = 12). Periodontitis was induced in the first maxillary molars 14 days before mating. Delivery occurred on the 21st day of gestation, and four offspring from each litter were evaluated (n = 48) for 30 days to verify physical and reflexological development. The first molars and alveolar bone were evaluated in 30‐day‐old animals using X‐ray microtomography and histopathological analysis. Differences between groups were considered significant if p < 0.05.Results: The P group had a lower number of live offspring (9.4 ± 1.9 pups) than the C group (11.4 ± 2.1, p = 0.03). The P offspring group showed lower weight (F = 1.17; p < 0.0001) and length (F = 3.47; p < 0.0001), as well as delayed hair growth (p = 0.01) and eruption of incisors (p = 0.001). The P offspring presented a delay in the motor development of postural straightening (p = 0.01), adult gait (p = 0.01), and negative geotaxis (p = 0.01). No developmental anomalies were observed in the maxillary first molars; however, the P group showed a decreased number (p = 0.02) and increased distance (p = 0.007) between the maxillary bone trabeculae.Conclusions: Periodontitis delayed physical and reflexological development and impaired maxillary bone quality in offspring.
- 3 April 2025
- Published by Wiley in Birth Defects Research
- Vol. 117 (4) , e2468
Postnatal Effects of Prenatal Exposure to Periodontitis in Wistar Rat Pups
Background: Periodontitis during pregnancy is associated with preterm births and low birth weight. This study evaluated how experimental periodontitis induced in female rats impacts the physical development, motor skills, and dental and maxillary development of their pups.Method: Pregnant Wistar rats were divided into the control group (C, n = 12) and the induced periodontal disease group (P, n = 12). Periodontitis was induced in the first maxillary molars 14 days before mating. Delivery occurred on the 21st day of gestation, and four offspring from each litter were evaluated (n = 48) for 30 days to verify physical and reflexological development. The first molars and alveolar bone were evaluated in 30‐day‐old animals using X‐ray microtomography and histopathological analysis. Differences between groups were considered significant if p < 0.05.Results: The P group had a lower number of live offspring (9.4 ± 1.9 pups) than the C group (11.4 ± 2.1, p = 0.03). The P offspring group showed lower weight (F = 1.17; p < 0.0001) and length (F = 3.47; p < 0.0001), as well as delayed hair growth (p = 0.01) and eruption of incisors (p = 0.001). The P offspring presented a delay in the motor development of postural straightening (p = 0.01), adult gait (p = 0.01), and negative geotaxis (p = 0.01). No developmental anomalies were observed in the maxillary first molars; however, the P group showed a decreased number (p = 0.02) and increased distance (p = 0.007) between the maxillary bone trabeculae.Conclusions: Periodontitis delayed physical and reflexological development and impaired maxillary bone quality in offspring.
- 24 March 2025
- Published by Springer Nature in Odontology
- Vol. 113 (4) , 1634-1642
Evaluation of the effects of prenatal exposure to pregabalin and postnatal analysis of dental and mandibular bone tissue development in rat offspring
Pregabalin is a gabapentinoid indicated for the treatment of peripheral neuropathic pain, fibromyalgia, and as an adjuvant therapy for epilepsy. The aim of this study was to evaluate the effects of pregabalin on postnatal development, odontogenesis, and mandibular trabecular tissue using computed microtomography. Pregnant rats (N = 24) were divided into two groups: control group/placebo (C), and treated group (PGB). The PGB group received 200 mg/kg of pregabalin via gavage during the embryonic period and the C group received distilled water under the same design. On the 21st day of pregnancy, delivery occurred naturally. On the first postnatal day, the litters were reduced to four pups (2 males and 2 females) and followed up for 30 days. On postnatal day 30, eight animals from each group were randomly selected for analysis of the lower right first molar and adjacent trabecular bone. In the maternal parameters, the data revealed a significant decrease in body weight gain in addition to a smaller number of live pups. In the postnatal analysis, the exposed pups showed a significant decrease in weight and length and a delay in the eruption of the incisor teeth. Microtomography analysis revealed a significant reduction in enamel volume, a lower volume and percentage of open pores, lower total porosity, and a higher percentage of bone volume. The findings of this study showed that pregabalin altered the eruption chronology of the incisors, decreased enamel volume, affected the microarchitecture of mandibular trabecular bone, and impaired postnatal development. CONCEA—CEUA-UEL n. 11,174.2018.36, State University of Londrina, (UEL), Londrina, Paraná, Brazil; retrospectively registered on August 21, 2018.
- 24 March 2025
- Published by Springer Nature in Odontology
- Vol. 113 (4) , 1634-1642
Evaluation of the effects of prenatal exposure to pregabalin and postnatal analysis of dental and mandibular bone tissue development in rat offspring
Pregabalin is a gabapentinoid indicated for the treatment of peripheral neuropathic pain, fibromyalgia, and as an adjuvant therapy for epilepsy. The aim of this study was to evaluate the effects of pregabalin on postnatal development, odontogenesis, and mandibular trabecular tissue using computed microtomography. Pregnant rats (N = 24) were divided into two groups: control group/placebo (C), and treated group (PGB). The PGB group received 200 mg/kg of pregabalin via gavage during the embryonic period and the C group received distilled water under the same design. On the 21st day of pregnancy, delivery occurred naturally. On the first postnatal day, the litters were reduced to four pups (2 males and 2 females) and followed up for 30 days. On postnatal day 30, eight animals from each group were randomly selected for analysis of the lower right first molar and adjacent trabecular bone. In the maternal parameters, the data revealed a significant decrease in body weight gain in addition to a smaller number of live pups. In the postnatal analysis, the exposed pups showed a significant decrease in weight and length and a delay in the eruption of the incisor teeth. Microtomography analysis revealed a significant reduction in enamel volume, a lower volume and percentage of open pores, lower total porosity, and a higher percentage of bone volume. The findings of this study showed that pregabalin altered the eruption chronology of the incisors, decreased enamel volume, affected the microarchitecture of mandibular trabecular bone, and impaired postnatal development. CONCEA—CEUA-UEL n. 11,174.2018.36, State University of Londrina, (UEL), Londrina, Paraná, Brazil; retrospectively registered on August 21, 2018.
- 18 December 2024
- Published by Wiley in Journal of Periodontology
- Vol. 96 (5) , 455-466
Effects of periodontal disease on the reproductive performance and offspring of Wistar rats
Background: Periodontitis can induce systemic inflammation, and it may affect the testicles and male reproductive performance. This study investigated the effects of periodontitis on the testicles, reproductive performance, and offspring development in male rats.Methods: Male Wistar rats were induced with periodontitis by ligating their first molars. After 14 days of inducing periodontal lesions, the animals were observed for an additional 54 days, corresponding to a complete cycle of spermatogenesis. Rats from the periodontitis group (GP, n = 12) and the control group (GC, n = 12) were paired with healthy females (n = 48) for 10 days, equivalent to 2 estrous cycles. Post‐mating, the males underwent microtomographic, histological, and reproductive parameter assessments.Results: Microtomographic analysis revealed higher porosity around the first molar in GP (26 ± 6%) and greater distance between the amelocemental junction and the alveolar bone (1.37 [1.12–1.90] mm), indicative of bone resorption. GP also exhibited significant decreases in final body weight, reduced Sertoli and Leydig cell counts, and lowered testosterone levels compared to GC. Significant morphological alterations in sperm tails were observed in GP compared to GC.Conclusions: Periodontitis adversely affected reproductive performance, evoking, and offspring development in male rats. These findings highlight the systemic impacts of periodontal disease on male reproductive health in an animal model.Plain Language Summary: Our study investigated how periodontitis can affect male reproductive health in rats and offspring development. We induced periodontitis in male rats and, after a full cycle of sperm production, these rats were mated with healthy females. We observed that the rats with periodontitis had worse reproductive performance compared to the control group without periodontitis. Additionally, the offspring of the rats with periodontitis showed signs of compromised intrauterine development and a higher incidence of congenital malformations. These results highlight that the inflammation caused by periodontitis can have adverse effects beyond the mouth, significantly impacting male reproductive health and offspring development. These findings suggest the need for further research into the clinical implications of periodontitis on reproductive health.
- 18 December 2024
- Published by Wiley in Journal of Periodontology
- Vol. 96 (5) , 455-466
Effects of periodontal disease on the reproductive performance and offspring of Wistar rats
Background: Periodontitis can induce systemic inflammation, and it may affect the testicles and male reproductive performance. This study investigated the effects of periodontitis on the testicles, reproductive performance, and offspring development in male rats.Methods: Male Wistar rats were induced with periodontitis by ligating their first molars. After 14 days of inducing periodontal lesions, the animals were observed for an additional 54 days, corresponding to a complete cycle of spermatogenesis. Rats from the periodontitis group (GP, n = 12) and the control group (GC, n = 12) were paired with healthy females (n = 48) for 10 days, equivalent to 2 estrous cycles. Post‐mating, the males underwent microtomographic, histological, and reproductive parameter assessments.Results: Microtomographic analysis revealed higher porosity around the first molar in GP (26 ± 6%) and greater distance between the amelocemental junction and the alveolar bone (1.37 [1.12–1.90] mm), indicative of bone resorption. GP also exhibited significant decreases in final body weight, reduced Sertoli and Leydig cell counts, and lowered testosterone levels compared to GC. Significant morphological alterations in sperm tails were observed in GP compared to GC.Conclusions: Periodontitis adversely affected reproductive performance, evoking, and offspring development in male rats. These findings highlight the systemic impacts of periodontal disease on male reproductive health in an animal model.Plain Language Summary: Our study investigated how periodontitis can affect male reproductive health in rats and offspring development. We induced periodontitis in male rats and, after a full cycle of sperm production, these rats were mated with healthy females. We observed that the rats with periodontitis had worse reproductive performance compared to the control group without periodontitis. Additionally, the offspring of the rats with periodontitis showed signs of compromised intrauterine development and a higher incidence of congenital malformations. These results highlight that the inflammation caused by periodontitis can have adverse effects beyond the mouth, significantly impacting male reproductive health and offspring development. These findings suggest the need for further research into the clinical implications of periodontitis on reproductive health.
- 24 November 2023
- Published by CSIRO Publishing in Reproduction, Fertility and Development
- Vol. 35 (18) , 750-759
Pregabalin alters reproductive performance in male mice and causes congenital anomalies in offspring
Context: Pregabalin is an anticonvulsant drug with analgesic activity for the treatment of neuropathic pain. Aims: To valuate the toxicity of pregabalin in reproductive parameters, spermatogenesis, and teratogenicity in the offspring of mice. Methods: Twenty male mice were randomly distributed into two groups: PGB group and group C (n = 10 per group). The animals in the PGB group received, via gavage, 200 mg/kg of pregabalin diluted in distilled water daily, for a period of 45 days. Group C received distilled water under the same experimental design. Key results: In the paternal parameters of the PGB group, there was a significant increase in the size of the testicles, morphological alterations in the spermatozoa, a decrease in the Johnsen score, an increase in the Leydig cells, and a decrease in the serum level of testosterone. In the intrauterine development parameters of females mated with males from the PGB group, a significant decrease in placental weight, weight and length of fetuses, and fetal viability rate was observed. There was a significant increase in the number of resorptions and post-implantation losses. The significant anomalies observed in the offspring were alteration in the size of the kidneys, absent metacarpals and phalanges, alteration in the sternum, and supernumerary thoracic vertebrae. Conclusion: Results suggest that pregabalin had toxic effects on the reproductive function of male mice and teratogenic potential. Implications: The findings of this study may provide new hypotheses, taking into account the risk–benefit ratio for male reproduction and offspring health.
- 24 November 2023
- Published by CSIRO Publishing in Reproduction, Fertility and Development
- Vol. 35 (18) , 750-759
Pregabalin alters reproductive performance in male mice and causes congenital anomalies in offspring
Context: Pregabalin is an anticonvulsant drug with analgesic activity for the treatment of neuropathic pain. Aims: To valuate the toxicity of pregabalin in reproductive parameters, spermatogenesis, and teratogenicity in the offspring of mice. Methods: Twenty male mice were randomly distributed into two groups: PGB group and group C (n = 10 per group). The animals in the PGB group received, via gavage, 200 mg/kg of pregabalin diluted in distilled water daily, for a period of 45 days. Group C received distilled water under the same experimental design. Key results: In the paternal parameters of the PGB group, there was a significant increase in the size of the testicles, morphological alterations in the spermatozoa, a decrease in the Johnsen score, an increase in the Leydig cells, and a decrease in the serum level of testosterone. In the intrauterine development parameters of females mated with males from the PGB group, a significant decrease in placental weight, weight and length of fetuses, and fetal viability rate was observed. There was a significant increase in the number of resorptions and post-implantation losses. The significant anomalies observed in the offspring were alteration in the size of the kidneys, absent metacarpals and phalanges, alteration in the sternum, and supernumerary thoracic vertebrae. Conclusion: Results suggest that pregabalin had toxic effects on the reproductive function of male mice and teratogenic potential. Implications: The findings of this study may provide new hypotheses, taking into account the risk–benefit ratio for male reproduction and offspring health.
- Open Access
- 21 October 2022
- Published by Universidade Estadual de Maringa in Acta Scientiarum. Health Sciences
- Vol. 45, e60003
Does Clonazepam induce salivary gland toxicity? A morphometric analysis of salivary glands in pregnant mice
Physiological alterations in pregnancy may induce changes in salivary secretion and a predisposition to anxiety disorders. Clonazepam, a benzodiazepine, is recommended as the first choice for the treatment of anxiety disorders. To date, no studies have described the consequences of using this drug on the salivary glands of pregnant women. Therefore, the objective was to evaluate the alterations induced by exposure to Clonazepam in the salivary glands of pregnant mice. Twenty-two pregnant Swiss mice were divided into a control group (C) and a treated group (T), which received distilled water and 10 mg Kg-1 of Clonazepam, respectively, via gavage, daily, from the 5 to the 17th day of pregnancy. On the 18th day, euthanasia and collection of salivary glands were carried out, and the salivary glands were histologically processed and morphometrically analyzed under an optical microscope. The area, perimeter, and diameter of the acini and the thickness of the secretory ducts of each gland were measured. Parametric data (expressed as mean and standard deviation) were analyzed using the Student's t-test, and non-parametric data (expressed as median and interquartile range) using the Mann-Whitney test (p <0.05). Parotid glands’ acinar diameters (C: 44.1 ± 12.2 µm; T: 36.5 ± 7.8 µm; p =0.002) and ductal thicknesses (C: 16.9 [14.3-21.3] µm; T: 15.1 [13.4-16.3] µm; p =0.043) were statistically smaller in the T group than in the C group. No further alterations were found in other parameters from parotid glands, nor in submandibular and sublingual glands. It is concluded that Clonazepam induces morphological alterations in the parotid glands of pregnant mice. These alterations are probably associated with hyposalivation and xerostomia, already described as a common complaint among the users of benzodiazepines. Further studies are, therefore, suggested to assess the implications of these findings on pregnant women’s oral health.
- 21 October 2022
- Published by Universidade Estadual de Maringa in Acta Scientiarum. Health Sciences
- Vol. 45, e60003
Open AccessDoes Clonazepam induce salivary gland toxicity? A morphometric analysis of salivary glands in pregnant mice
Physiological alterations in pregnancy may induce changes in salivary secretion and a predisposition to anxiety disorders. Clonazepam, a benzodiazepine, is recommended as the first choice for the treatment of anxiety disorders. To date, no studies have described the consequences of using this drug on the salivary glands of pregnant women. Therefore, the objective was to evaluate the alterations induced by exposure to Clonazepam in the salivary glands of pregnant mice. Twenty-two pregnant Swiss mice were divided into a control group (C) and a treated group (T), which received distilled water and 10 mg Kg-1 of Clonazepam, respectively, via gavage, daily, from the 5 to the 17th day of pregnancy. On the 18th day, euthanasia and collection of salivary glands were carried out, and the salivary glands were histologically processed and morphometrically analyzed under an optical microscope. The area, perimeter, and diameter of the acini and the thickness of the secretory ducts of each gland were measured. Parametric data (expressed as mean and standard deviation) were analyzed using the Student's t-test, and non-parametric data (expressed as median and interquartile range) using the Mann-Whitney test (p <0.05). Parotid glands’ acinar diameters (C: 44.1 ± 12.2 µm; T: 36.5 ± 7.8 µm; p =0.002) and ductal thicknesses (C: 16.9 [14.3-21.3] µm; T: 15.1 [13.4-16.3] µm; p =0.043) were statistically smaller in the T group than in the C group. No further alterations were found in other parameters from parotid glands, nor in submandibular and sublingual glands. It is concluded that Clonazepam induces morphological alterations in the parotid glands of pregnant mice. These alterations are probably associated with hyposalivation and xerostomia, already described as a common complaint among the users of benzodiazepines. Further studies are, therefore, suggested to assess the implications of these findings on pregnant women’s oral health.
- 12 October 2022
- Published by CSIRO Publishing in Reproduction, Fertility and Development
- Vol. 34 (17) , 1099-1106
Congenital anomalies and spontaneous abortion in mice resulting from the use of escitalopram
Context: Escitalopram (ESC) use during pregnancy has not been associated with teratogenic effects in fetuses. Aims: To investigate whether ESC administered during pregnancy in mice induces maternal toxicity and teratogenicity in offspring. Methods: Treated mice groups G1 and control G0 (n = 15 per group). Administration of ESC (G1) and saline solution (G0) during pregnancy and euthanasia on the 18th day. Pregnant female mice were treated with ESC (20 mg/kg, via gavage) or saline solution (control group) from the 5th to the 17th day of gestation, when implantation was consolidated. During intraembryonic development until the day before delivery, the drug had an influence on the development of alterations from its maintenance in the uterine environment and its development to the disturbance causing skeletal or visceral malformations. Key results: The intrauterine development parameters that were altered by ESC treatment were: number of resorptions (G0: [0.93 ± 0.24]); G1: [3.33 ± 0.51]), post-implantation loss (G0: [3.95 ± 1.34], G1: [13.75 ± 3.62]) and reduced fetal viability: [97.30 ± 1.00]; G1: [81.09 ± 6.22]). Regarding fetal formation, the treated group had visceral malformations with a significant frequency: cleft palate (G0: [1.0%], G1: [11.86%]) and reduced kidneys (G0: [0%]; G1: [10.17%]). Regarding skeletal malformations, a higher frequency was observed in the following parameters: incomplete supraoccipital ossification (G0: [0%], G1: [15.25]), absence of ribs (G0: [0%], G1 (G0: [0%], G1 [15.25%]) and absence of one or more of the foot phalanges (G0: [1.0%]; 64%]). Conclusion: Results indicate that ESC is an embryotoxic and teratogenic drug. Implications: Until further studies are performed, greater caution is necessary in prescribing the drug to pregnant women.
- 12 October 2022
- Published by CSIRO Publishing in Reproduction, Fertility and Development
- Vol. 34 (17) , 1099-1106
Congenital anomalies and spontaneous abortion in mice resulting from the use of escitalopram
Context: Escitalopram (ESC) use during pregnancy has not been associated with teratogenic effects in fetuses. Aims: To investigate whether ESC administered during pregnancy in mice induces maternal toxicity and teratogenicity in offspring. Methods: Treated mice groups G1 and control G0 (n = 15 per group). Administration of ESC (G1) and saline solution (G0) during pregnancy and euthanasia on the 18th day. Pregnant female mice were treated with ESC (20 mg/kg, via gavage) or saline solution (control group) from the 5th to the 17th day of gestation, when implantation was consolidated. During intraembryonic development until the day before delivery, the drug had an influence on the development of alterations from its maintenance in the uterine environment and its development to the disturbance causing skeletal or visceral malformations. Key results: The intrauterine development parameters that were altered by ESC treatment were: number of resorptions (G0: [0.93 ± 0.24]); G1: [3.33 ± 0.51]), post-implantation loss (G0: [3.95 ± 1.34], G1: [13.75 ± 3.62]) and reduced fetal viability: [97.30 ± 1.00]; G1: [81.09 ± 6.22]). Regarding fetal formation, the treated group had visceral malformations with a significant frequency: cleft palate (G0: [1.0%], G1: [11.86%]) and reduced kidneys (G0: [0%]; G1: [10.17%]). Regarding skeletal malformations, a higher frequency was observed in the following parameters: incomplete supraoccipital ossification (G0: [0%], G1: [15.25]), absence of ribs (G0: [0%], G1 (G0: [0%], G1 [15.25%]) and absence of one or more of the foot phalanges (G0: [1.0%]; 64%]). Conclusion: Results indicate that ESC is an embryotoxic and teratogenic drug. Implications: Until further studies are performed, greater caution is necessary in prescribing the drug to pregnant women.
- 1 October 2022
- Published by Springer Nature in Odontology
- Vol. 111 (2) , 401-408
Intrauterine exposure to omeprazole increases the risk of teeth morphological anomalies in the offspring of a murine model
Conditions experienced in early life have long-lasting effects on offspring health. Despite this, little is known about how maternal exposure to drugs during pregnancy affects offspring teeth morphogenesis. In humans, omeprazole is a common drug used to mitigate Gastroesophageal Reflux Disease. Importantly, omeprazole is a non-specific proton-pump inhibitor, which may inhibit the proton pumps expressed in the developing tooth germ. To date, however, the effects of intrauterine life exposure to omeprazole on offspring tooth development remain unknown. In this study, we addressed this gap in a murine model. Pregnant female Swiss mice were exposed to daily doses of 40 mg/kg of omeprazole from the 5th to the 17th day of pregnancy and the effects of such exposure on offspring odontogenesis parameters such as morphological abnormalities, disruptions in the ameloblast and odontoblast layers and the presence of dentin matrix were measured. Omeprazole exposure significantly increased the prevalence (control: 21.6%; treatment: 60%; p = 0.001) and the risk (posterior mean and 95% credible interval; control: 0.230 [0.129; 0.347]; treatment: 0.593 [0.449; 0.730]) of offspring teeth morphological abnormalities, although there were no statistically significant effects of omeprazole exposure on other parameters of tooth development. These findings suggest that there are potential side-effects to offspring oral health of omeprazole use during pregnancy.
- 1 October 2022
- Published by Springer Nature in Odontology
- Vol. 111 (2) , 401-408
Intrauterine exposure to omeprazole increases the risk of teeth morphological anomalies in the offspring of a murine model
Conditions experienced in early life have long-lasting effects on offspring health. Despite this, little is known about how maternal exposure to drugs during pregnancy affects offspring teeth morphogenesis. In humans, omeprazole is a common drug used to mitigate Gastroesophageal Reflux Disease. Importantly, omeprazole is a non-specific proton-pump inhibitor, which may inhibit the proton pumps expressed in the developing tooth germ. To date, however, the effects of intrauterine life exposure to omeprazole on offspring tooth development remain unknown. In this study, we addressed this gap in a murine model. Pregnant female Swiss mice were exposed to daily doses of 40 mg/kg of omeprazole from the 5th to the 17th day of pregnancy and the effects of such exposure on offspring odontogenesis parameters such as morphological abnormalities, disruptions in the ameloblast and odontoblast layers and the presence of dentin matrix were measured. Omeprazole exposure significantly increased the prevalence (control: 21.6%; treatment: 60%; p = 0.001) and the risk (posterior mean and 95% credible interval; control: 0.230 [0.129; 0.347]; treatment: 0.593 [0.449; 0.730]) of offspring teeth morphological abnormalities, although there were no statistically significant effects of omeprazole exposure on other parameters of tooth development. These findings suggest that there are potential side-effects to offspring oral health of omeprazole use during pregnancy.
- 31 August 2020
- Published by Springer Nature in Odontology
- Vol. 109 (2) , 336-348
Methylphenidate effects on mice odontogenesis and connections with human odontogenesis
The purpose of this study is to evaluate the effects of Methylphenidate exposure on mice odontogenesis and connect them by bioinformatics with human odontogenesis. Thirty-two pregnant Swiss mice were divided into treated group and control group, which received, respectively, 5 mg/kg of Methylphenidate and saline solution from the 5th to the 17th day of pregnancy. The mouse embryos tooth germs were analyzed through optical microscopy, and the data collected were analyzed statistically by Fisher’s exact test. The presence and similarity of Methylphenidate-associated genes (Pharmgkb database) in both organisms and their interaction with dental development genes (AmiGO2 database) were verified on STRING database. Rates of tooth germ malformations were higher in treated than in control group (Control: 18; Treated: 27; p = 0.035). Mouse embryo malformations were connected with 238 interactions between 69 dental development genes with 35 Methylphenidate genes. Fourteen interactions for four Methylphenidate genes with four dental development genes, with human experimental data, were connected with mouse phenotype data. By homology, the interactions and conservation of proteins/genes may indicate similar outcomes for both organisms. The exposure to Methylphenidate during pregnancy affected odontogenesis in mouse embryos and may affect human odontogenesis. The study of malformations in mice, with a bioinformatics approach, could contribute to understanding of the Methylphenidate effect on embryo development. These results may provide novel hypotheses for further testing and reinforce the FDA protocol: as Methylphenidate is included in category C, its use during pregnancy should be considered if the benefits outweigh the risks.
- 31 August 2020
- Published by Springer Nature in Odontology
- Vol. 109 (2) , 336-348
Methylphenidate effects on mice odontogenesis and connections with human odontogenesis
The purpose of this study is to evaluate the effects of Methylphenidate exposure on mice odontogenesis and connect them by bioinformatics with human odontogenesis. Thirty-two pregnant Swiss mice were divided into treated group and control group, which received, respectively, 5 mg/kg of Methylphenidate and saline solution from the 5th to the 17th day of pregnancy. The mouse embryos tooth germs were analyzed through optical microscopy, and the data collected were analyzed statistically by Fisher’s exact test. The presence and similarity of Methylphenidate-associated genes (Pharmgkb database) in both organisms and their interaction with dental development genes (AmiGO2 database) were verified on STRING database. Rates of tooth germ malformations were higher in treated than in control group (Control: 18; Treated: 27; p = 0.035). Mouse embryo malformations were connected with 238 interactions between 69 dental development genes with 35 Methylphenidate genes. Fourteen interactions for four Methylphenidate genes with four dental development genes, with human experimental data, were connected with mouse phenotype data. By homology, the interactions and conservation of proteins/genes may indicate similar outcomes for both organisms. The exposure to Methylphenidate during pregnancy affected odontogenesis in mouse embryos and may affect human odontogenesis. The study of malformations in mice, with a bioinformatics approach, could contribute to understanding of the Methylphenidate effect on embryo development. These results may provide novel hypotheses for further testing and reinforce the FDA protocol: as Methylphenidate is included in category C, its use during pregnancy should be considered if the benefits outweigh the risks.
- 1 July 2020
- Published by Wolters Kluwer Health in Clinical Dysmorphology
- Vol. 29 (3) , 165-166
Partial monosomy of chromosome 21 and congenital malformations monosomy of chromosome 21 and malformations
- 1 July 2020
- Published by Wolters Kluwer Health in Clinical Dysmorphology
- Vol. 29 (3) , 165-166
Partial monosomy of chromosome 21 and congenital malformations monosomy of chromosome 21 and malformations